Analysis of prognostic factor in 52 castration-resistant prostate cancer treated with docetaxel

Analysis of prognostic factor in 52 castration-resistant prostate cancer treated with docetaxel

The prognostic factor was retrospectively analyzed in 52 castration-resistant prostate cancer treated with docetaxel (DTX) in our institutions from April, 2006 to August, 2009. The treatment outcomes were decided with prostate specific antigen (PSA) progression-free survival and overall survival. Th...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 58(2012), 1 vom: 07. Jan., Seite 7-11
1. Verfasser: Saitou, Yoshitaka (VerfasserIn)
Weitere Verfasser: Hatanaka, Yuji, Imanishi, Masaaki, Ohzeki, Takayuki, Hashimoto, Kiyoshi, Sugimoto, Koichi, Esa, Atsunobu, Kajikawa, Hiroshi, Yasuda, Muneo, Yamamoto, Yutaka, Uemura, Hirotsugu
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Antineoplastic Agents Taxoids Docetaxel 15H5577CQD Prostate-Specific Antigen EC 3.4.21.77